SCHLIEREN, Switzerland--(BUSINESS WIRE)--Biognosys, a leader in next-generation proteomics solutions for life sciences research and development, announced today the launch of Spectronaut 15. The ...
Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment ...
Spectronaut ® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the ...
Highlights include the launch of Spectronaut® 16, which has undergone one of its most transformative upgrades to date, and innovations to Biognosys’ proprietary TrueTarget™ and TrueDiscovery™ ...
Data-independent acquisition (DIA) has become the method of choice for large-scale discovery proteomics. Its application for single-cell analysis promises to be more sensitive, robust, and ...
Biognosys AG has announced the second release of its Spectronaut™ software for analysis of Hyper Reaction Monitoring (HRM) data. HRM is a targeted proteomics technology that enables reproducible and ...
ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch ...
(MENAFN- GlobeNewsWire - Nasdaq) ZURICH and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Biognosys, a global leader in mass spectrometry-based proteomics solutions, announces the launch of Spectronaut ® ...
This latest release of Biognosys’ flagship software for DIA analysis comes with significant improvements in peptide and protein level identifications, increased depth of candidates' discovery rate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results